June 10, 2020
The list of drugs for the treatment of patients with expensive nosologies expanded in Russia
In accordance with the order of the Government of the Russian Federation, the list of drugs necessary to provide patients suffering from unspecified aplastic anemia and hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower) has been supplemented.

In accordance with the order of the Government of the Russian Federation:

  • Patients with unspecified aplastic anemia are provided with cyclosporine;
  • Patients with hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower) are provided with eptacog alfa (activated).

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.
This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
Ok, I agree
Close
Subscribe to newsletter
Subscribe to our newsletter to get regular updates from us on the changes of reimbursement systems (>100 reimbursement stakeholders in 12 EU countries)